South Korea · Delayed Price · Currency is KRW TegoScience Statistics
Total Valuation
TegoScience has a market cap or net worth of KRW 100.56 billion. The enterprise value is 65.21 billion.
| Market Cap | 100.56B |
| Enterprise Value | 65.21B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TegoScience has 8.01 million shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | 8.01M |
| Shares Outstanding | 8.01M |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | 42.45% |
| Owned by Institutions (%) | 0.17% |
| Float | 4.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.93 |
| PB Ratio | 1.99 |
| P/TBV Ratio | 2.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.30 |
| EV / Sales | 10.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -20.93 |
Financial Position
The company has a current ratio of 16.05, with a Debt / Equity ratio of 0.32.
| Current Ratio | 16.05 |
| Quick Ratio | 14.90 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.18 |
| Interest Coverage | -3.53 |
Financial Efficiency
Return on equity (ROE) is -14.01% and return on invested capital (ROIC) is -24.90%.
| Return on Equity (ROE) | -14.01% |
| Return on Assets (ROA) | -4.23% |
| Return on Invested Capital (ROIC) | -24.90% |
| Return on Capital Employed (ROCE) | -5.94% |
| Weighted Average Cost of Capital (WACC) | 8.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.09 |
| Inventory Turnover | 1.04 |
Taxes
| Income Tax | -1.09B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.60% in the last 52 weeks. The beta is 0.87, so TegoScience's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -21.60% |
| 50-Day Moving Average | 13,509.60 |
| 200-Day Moving Average | 16,283.30 |
| Relative Strength Index (RSI) | 44.35 |
| Average Volume (20 Days) | 11,654 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TegoScience had revenue of KRW 5.94 billion and -7.01 billion in losses. Loss per share was -876.00.
| Revenue | 5.94B |
| Gross Profit | 4.00B |
| Operating Income | -4.42B |
| Pretax Income | -8.11B |
| Net Income | -7.01B |
| EBITDA | -3.87B |
| EBIT | -4.42B |
| Loss Per Share | -876.00 |
Balance Sheet
The company has 51.44 billion in cash and 16.16 billion in debt, with a net cash position of 35.28 billion or 4,406.94 per share.
| Cash & Cash Equivalents | 51.44B |
| Total Debt | 16.16B |
| Net Cash | 35.28B |
| Net Cash Per Share | 4,406.94 |
| Equity (Book Value) | 50.44B |
| Book Value Per Share | 6,313.00 |
| Working Capital | 54.59B |
Cash Flow
In the last 12 months, operating cash flow was -3.07 billion and capital expenditures -49.30 million, giving a free cash flow of -3.12 billion.
| Operating Cash Flow | -3.07B |
| Capital Expenditures | -49.30M |
| Depreciation & Amortization | 550.43M |
| Net Borrowing | 26.79B |
| Free Cash Flow | -3.12B |
| FCF Per Share | -389.20 |
Margins
Gross margin is 67.41%, with operating and profit margins of -74.48% and -118.04%.
| Gross Margin | 67.41% |
| Operating Margin | -74.48% |
| Pretax Margin | -136.47% |
| Profit Margin | -118.04% |
| EBITDA Margin | -65.21% |
| EBIT Margin | -74.48% |
| FCF Margin | n/a |
Dividends & Yields
TegoScience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.11% |
| Shareholder Yield | 0.11% |
| Earnings Yield | -6.97% |
| FCF Yield | -3.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 11, 2018. It was a forward split with a ratio of 2.
| Last Split Date | Jul 11, 2018 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
TegoScience has an Altman Z-Score of 3.71 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.71 |
| Piotroski F-Score | 2 |